Skip to main content
ADAG logo

ADAG

Compare

Adagene Inc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Powered by its proprietary Dynamic Precision Library (DPL) platform, composed of NEObody™, SAFEbody®, and POWERbody™ technologies, Adagene’s highly differentiated pipeline features novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.

Current Price

Profile
Valuation (TTM)
Market Cap
P/E
EV
P/B
Shares Out
P/Sales
Revenue
EV/EBITDA

Adagene Inc (ADAG) Company Profile

ADAG Company Information

Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies.

Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs.

Powered by its proprietary Dynamic Precision Library (DPL) platform, composed of NEObody™, SAFEbody®, and POWERbody™ technologies, Adagene’s highly differentiated pipeline features novel immunotherapy programs.

Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

China

ADAG Key Officers

Key officers data coming soon

ADAG Company Profile

Adagene Inc (ADAG) is a Healthcare company in the Biotechnology industry. It trades on NASDAQ. The company is based in China.

Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Powered by its proprietary Dynamic Precision Library (DPL) platform, composed of NEObody™, SAFEbody®, and POWERbody™ technologies, Adagene’s highly differentiated pipeline features novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.

See the full Adagene Inc profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if ADAG is a good investment.